Developing a first-in-class small molecule drug for inflammatory disease
European Pharmaceutical Review
NOVEMBER 9, 2023
It is caused by the natural aging process and can be a risk for people who have diabetes, are obese, perform little to no exercise, have a poor nutrition, or smoke. To ensure an efficient process, MyMD works closely with the contract manufacturing organisation (CMO) focusing on automation and process improvement.
104 
Let's personalize your content